Turnaround & Cost Estimator

Your numbers,
before you call.

Configure your specimen workflow. Turnaround hours, cost per case, and compliance score update in real time on the right.

No commitment Β· Assessment in 24 hours Β· HIPAA-compliant

Live Estimate
Estimated Turnaround
120
hours
5–7 business days
Cost per Case
$42
volume discount applied
Monthly Total
$2,100
projected spend
Quality Audit Compliance Score
97%
CAP Β· CLIA Β· ISO 15189 protocols active
CAP
CLIA
ISO 15189
Verified Lab

Estimates are based on standard workflow parameters and current lab capacity. Final pricing confirmed upon specimen submission and protocol review.

Audit Tab 01

Accreditation
without asterisks.

Every badge on this page links to a verifiable certificate. We operate under three independent accreditation bodies β€” not because compliance requires it, but because our clients' results demand it.

CAP
Active

College of American Pathologists

Since
2014
Renewal
Mar 2026
Verify Certificate

Biennial on-site inspection covering 2,800+ checklist items across pre-analytic, analytic, and post-analytic phases. Proficiency testing in 42 analyte categories.

  • Slide preparation & staining QC
  • Reagent lot-to-lot validation
  • Pathologist credentialing audit
  • PT result submission within 30 days
CLIA
Active

Clinical Laboratory Improvement Amendments

Since
2011
Renewal
Nov 2025
Verify Certificate

Federal certificate covering all human specimen testing. Encompasses personnel qualifications, QC procedures, proficiency testing, and patient test management.

  • High-complexity testing certificate
  • Director qualification on file
  • Daily QC documentation
  • Test system validation records
ISO 15189
Active

Medical Laboratories β€” Requirements for Quality & Competence

Since
2019
Renewal
Jun 2026
Verify Certificate

International standard specifying quality management and technical competence requirements. Covers measurement uncertainty, traceability, and pre-examination processes.

  • Risk management framework (ISO 22367)
  • Measurement uncertainty budgets
  • Reference interval verification
  • Complaint & nonconformity tracking
Audit Tab 02

Chain of
custody.

From arrival dock to signed report β€” every hand-off logged, timestamped, and auditable within 30 seconds.

22 hr
Avg. H&E Turnaround
standard workflow
99.97%
Chain Integrity Rate
last 12 months
0.08%
Discrepancy Rate
below CAP 0.5% threshold
01

Specimen Receipt & Accessioning

Barcode-scanned within 15 min of arrival. Condition assessed against submission form. Discrepancies trigger immediate client notification via LIS alert.

0–15 min
03

Automated Tissue Processing

Leica ASP300S tissue processor. Overnight cycle for FFPE; rapid 4-hour protocol available for STAT cases. Temperature and reagent logs archived for 10 years.

4–12 hr
05

Staining & Coverslipping

Automated H&E and special stain platforms. IHC panels on Leica Bond-RX with positive and negative controls on every run. Digital scan triggers QC check before pathologist review.

2–4 hr
02

Gross Examination & Cassetting

Pathologist assistant performs gross description per CAP protocol. Tissue sections selected, labeled with unique cassette ID, and routed to processing queue.

15 min–2 hr
04

Embedding & Sectioning

Paraffin embedding at 60Β°C. Microtome sections at 3–5 Β΅m. Section quality reviewed before staining β€” warped or compressed sections re-cut automatically.

1–2 hr
06

Pathologist Sign-Out & Report

Board-certified pathologist review. Final report delivered to LIS within SLA window. Addenda tracked with timestamp. Second-opinion escalation available within 4 hours.

SLA window
Audit Tab 03

Staining
consistency.

Drag the divider to compare raw vs. optimized staining. Every run includes calibration standards β€” deviation triggers immediate re-run, not a workaround.

< 0.02 OD
Lot-to-Lot Variance
99.8%
Run Controls Pass Rate
Leica Bond-RX
Stain Platform
Hematoxylin and eosin stained breast tissue section before quality control showing uneven staining
Before Optimization

Uneven hematoxylin β€” nuclear detail obscured

Sub-optimal staining β€” requires re-run
Optimized hematoxylin and eosin stained breast carcinoma section with crisp nuclear detail
After Optimization

Crisp nuclear detail β€” mitotic figures countable

Diagnostic quality confirmed β€” cleared for pathologist review
Hematoxylin and eosin stained breast tissue section before quality control showing uneven staining
Optimized hematoxylin and eosin stained breast carcinoma section with crisp nuclear detail
Before
After
Drag to compare
Audit Tab 04

Digital
pathology.

Whole-slide imaging at 0.25 Β΅m/pixel. Every slide scanned, annotated, and delivered to your existing LIS β€” no workflow disruption, no new software to install.

0.25 Β΅m/px
Scan Resolution
12+
Platforms Supported
< 3 min
Scan Time per Slide
10 years
Storage Retention
Whole slide image of breast carcinoma tissue section at 40x magnification with pathologist annotations
40Γ— Β· 0% scanned
Specimen ID
SP-2026-04471
3 annotations

Click annotation markers above to view pathologist notes. All annotations are embedded in the HL7/FHIR report and synchronized to your LIS within 60 seconds of sign-out.

LIS / LIMS Compatibility

Native integration = direct HL7/FHIR feed. API = REST endpoint with full documentation.

LIS
Cerner PowerChart
native
Epic Beaker
native
Sunquest
native
Meditech
api
LIMS
LabVantage
native
STARLIMS
native
LabWare
api
WSI
Aperio eSlide Manager
native
Philips IntelliSite
native
Hamamatsu NDP.serve
api
Imaging
Sectra IDS7
native
Research
REDCap
api

Don't see your platform? Our integration team configures custom HL7 mappings in 3–5 business days. No middleware required.

Primary Conversion

Get Your
Lab Assessment.

A board-certified pathologist and lab operations consultant review your current workflow and return a written assessment within 24 hours.

Confidential Β· HIPAA-compliant Β· No spam

Secondary Conversion
PDF

Specimen Submission Guide

Complete prep protocol: fixation times, labeling requirements, shipping conditions, and rejection criteria for all specimen types.

Why Specimen

22-hour average H&E turnaround
Confirmed across 14,000+ cases in 2025
Triple-accredited since 2014
CAP Β· CLIA Β· ISO 15189 β€” no gaps, no lapses
Serving 47 hospital systems
Including 3 NCI-designated cancer centers
0.08% discrepancy rate
6Γ— below the CAP 0.5% threshold